Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.

European Journal of Internal Medicine
Sake J van der WallGLORIA-AF Investigators

Abstract

Prospective data on nonvitamin-K-antagonist oral anticoagulant (NOAC) management during cardiovascular interventions are limited. We therefore evaluated the safety and effectiveness of uninterrupted dabigatran therapy as well as dabigatran management during atrial fibrillation (AF)-cardioversions, AF-ablations, pacemaker implantations and coronary angiography and/or stenting procedures. GLORIA-AF is an international registry programme involving patients with newly diagnosed AF. Dabigatran users were followed for ≤2 years. The primary outcome was occurrence of stroke/systemic embolism and major bleeding ≤8 weeks after a cardiovascular intervention during uninterrupted dabigatran therapy. During the 2-year follow-up, 599 cardiovascular interventions were identified in 479 eligible patients. 412/599 (69%) interventions were performed with uninterrupted dabigatran therapy: 299/354 (84%) AF-cardioversions, 38/89 (43%) AF-ablations, 25/58 (43%) pacemaker implantations, and 50/98 (51%) coronary angiography and/or stenting procedures. During an average follow-up of 8.4 weeks after intervention, one major bleed and one systemic embolic event occurred (risk 0.25% for both outcomes; 95% confidence interval, 0.01%-1.36%). More than two thi...Continue Reading

References

Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Nov 28, 2012·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Pascal VranckxFrank W G Leebeek
Jan 31, 2013·The American Journal of Cardiology·Christopher P RowleyMichael R Gold
Jul 16, 2013·Journal of the American College of Cardiology·K E Juhani AiraksinenJuha E K Hartikainen
Jul 31, 2013·Journal of Cardiovascular Electrophysiology·John M JenningsG Neal Kay
Sep 19, 2014·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Morten Lock HansenChristian Torp-Pedersen
May 16, 2015·European Heart Journal·Riccardo CappatoUNKNOWN VENTURE-AF Investigators
Jun 23, 2015·The New England Journal of Medicine·James D DouketisUNKNOWN BRIDGE Investigators
Aug 5, 2015·The American Journal of Medicine·Menno V HuismanUNKNOWN GLORIA-AF Investigators
Oct 25, 2016·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Anene UkaigweGerald V Naccarrelli
Mar 21, 2017·The New England Journal of Medicine·Hugh CalkinsUNKNOWN RE-CIRCUIT Investigators
Mar 27, 2018·European Heart Journal·Paulus KirchhofLuigi Di Biase
Oct 13, 2018·Journal of the American College of Cardiology·Dipak KotechaPaulus Kirchhof
Sep 11, 2019·European Heart Journal·Juhani KnuutiUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

AJNR. American Journal of Neuroradiology
L MurphyE C Kavanagh
Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine
Amer ZeidanMichael Streiff
Nihon rinsho. Japanese journal of clinical medicine
Masahiro Yasaka
© 2021 Meta ULC. All rights reserved